The relationship between vascular and metabolic characteristics of primary breast tumours

Scott Ian Kay Semple, Fiona Jane Gilbert, Thomas William Redpath, Roger T Staff, Trevor Sean Ahearn, Andrew Welch, Steven Darryll Heys, A. W. Hutcheon, E. H. Smyth, S. Chaturvedi

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association (P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44% of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.

Original languageEnglish
Pages (from-to)2038-2045
Number of pages7
JournalEuropean Radiology
Volume14
Issue number11
DOIs
Publication statusPublished - Nov 2004

Keywords

  • breast cancer
  • dynamic MRI
  • FDG PET
  • kinetic modelling
  • POSITRON-EMISSION-TOMOGRAPHY
  • BLOOD-FLOW
  • NEOADJUVANT CHEMOTHERAPY
  • CANCER
  • MRI
  • PERMEABILITY
  • ENHANCEMENT
  • PARAMETERS
  • THERAPY

Cite this

The relationship between vascular and metabolic characteristics of primary breast tumours. / Semple, Scott Ian Kay; Gilbert, Fiona Jane; Redpath, Thomas William; Staff, Roger T; Ahearn, Trevor Sean; Welch, Andrew; Heys, Steven Darryll; Hutcheon, A. W.; Smyth, E. H.; Chaturvedi, S.

In: European Radiology, Vol. 14, No. 11, 11.2004, p. 2038-2045.

Research output: Contribution to journalArticle

Semple, Scott Ian Kay ; Gilbert, Fiona Jane ; Redpath, Thomas William ; Staff, Roger T ; Ahearn, Trevor Sean ; Welch, Andrew ; Heys, Steven Darryll ; Hutcheon, A. W. ; Smyth, E. H. ; Chaturvedi, S. / The relationship between vascular and metabolic characteristics of primary breast tumours. In: European Radiology. 2004 ; Vol. 14, No. 11. pp. 2038-2045.
@article{56c62f2e90dc4b6fa02059607660f0eb,
title = "The relationship between vascular and metabolic characteristics of primary breast tumours",
abstract = "The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association (P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44{\%} of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.",
keywords = "breast cancer, dynamic MRI, FDG PET, kinetic modelling, POSITRON-EMISSION-TOMOGRAPHY, BLOOD-FLOW, NEOADJUVANT CHEMOTHERAPY, CANCER, MRI, PERMEABILITY, ENHANCEMENT, PARAMETERS, THERAPY",
author = "Semple, {Scott Ian Kay} and Gilbert, {Fiona Jane} and Redpath, {Thomas William} and Staff, {Roger T} and Ahearn, {Trevor Sean} and Andrew Welch and Heys, {Steven Darryll} and Hutcheon, {A. W.} and Smyth, {E. H.} and S. Chaturvedi",
year = "2004",
month = "11",
doi = "10.1007/s00330-004-2454-6",
language = "English",
volume = "14",
pages = "2038--2045",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - The relationship between vascular and metabolic characteristics of primary breast tumours

AU - Semple, Scott Ian Kay

AU - Gilbert, Fiona Jane

AU - Redpath, Thomas William

AU - Staff, Roger T

AU - Ahearn, Trevor Sean

AU - Welch, Andrew

AU - Heys, Steven Darryll

AU - Hutcheon, A. W.

AU - Smyth, E. H.

AU - Chaturvedi, S.

PY - 2004/11

Y1 - 2004/11

N2 - The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association (P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44% of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.

AB - The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association (P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44% of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.

KW - breast cancer

KW - dynamic MRI

KW - FDG PET

KW - kinetic modelling

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - BLOOD-FLOW

KW - NEOADJUVANT CHEMOTHERAPY

KW - CANCER

KW - MRI

KW - PERMEABILITY

KW - ENHANCEMENT

KW - PARAMETERS

KW - THERAPY

U2 - 10.1007/s00330-004-2454-6

DO - 10.1007/s00330-004-2454-6

M3 - Article

VL - 14

SP - 2038

EP - 2045

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 11

ER -